Croucher PI - Search Results

1

Melphalan modifies the bone microenvironment by enhancing osteoclast formation.

Chai RC, McDonald MM, Terry RL, Kovačić N, Down JM, Pettitt JA, Mohanty ST, Shah S, Haffari G, Xu J, Gillespie MT, Rogers MJ, Price JT, Croucher PI, Quinn JMW. Chai RC, et al. Among authors: croucher pi. Oncotarget. 2017 Jul 10;8(40):68047-68058. doi: 10.18632/oncotarget.19152. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978095 Free PMC article.

2

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

Shipman CM, Rogers MJ, Apperley JF, Russell RG, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Br J Haematol. 1997 Sep;98(3):665-72. doi: 10.1046/j.1365-2141.1997.2713086.x. Br J Haematol. 1997. PMID: 9332325 Free article.

3

The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway.

Shipman CM, Croucher PI, Russell RG, Helfrich MH, Rogers MJ. Shipman CM, et al. Among authors: croucher pi. Cancer Res. 1998 Dec 1;58(23):5294-7. Cancer Res. 1998. PMID: 9850051

4

The pharmacology of bisphosphonates and new insights into their mechanisms of action.

Russell RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleisch HA. Russell RG, et al. Among authors: croucher pi. J Bone Miner Res. 1999 Oct;14 Suppl 2:53-65. doi: 10.1002/jbmr.5650140212. J Bone Miner Res. 1999. PMID: 10510215 Free article. Review.

5

Bisphosphonates: pharmacology, mechanisms of action and clinical uses.

Russell RG, Croucher PI, Rogers MJ. Russell RG, et al. Among authors: croucher pi. Osteoporos Int. 1999;9 Suppl 2:S66-80. doi: 10.1007/pl00004164. Osteoporos Int. 1999. PMID: 10525729 Review. No abstract available.

6

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.

Shipman CM, Vanderkerken K, Rogers MJ, Lippitt JM, Asosingh K, Hughes DE, Van Camp B, Russell RG, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Br J Haematol. 2000 Oct;111(1):283-6. doi: 10.1046/j.1365-2141.2000.02310.x. Br J Haematol. 2000. PMID: 11091214 Free article.

7

Bisphosphonates--mechanisms of action in multiple myeloma.

Shipman CM, Rogers MJ, Vanderkerken K, Van Camp B, Graham R, Russell G, Croucher PI. Shipman CM, et al. Among authors: croucher pi. Acta Oncol. 2000;39(7):829-35. doi: 10.1080/028418600750063587. Acta Oncol. 2000. PMID: 11145441

8

The Fas/Fas ligand system inhibits differentiation of murine osteoblasts but has a limited role in osteoblast and osteoclast apoptosis.

Kovacić N, Lukić IK, Grcević D, Katavić V, Croucher P, Marusić A. Kovacić N, et al. J Immunol. 2007 Mar 15;178(6):3379-89. doi: 10.4049/jimmunol.178.6.3379. J Immunol. 2007. PMID: 17339432 Free PMC article.

9

Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes.

Grcević D, Kusec R, Kovacić N, Lukić A, Lukić IK, Ivcević S, Nemet D, Seiwerth RS, Ostojić SK, Croucher PI, Marusić A. Grcević D, et al. Among authors: croucher pi. Leuk Res. 2010 Jun;34(6):742-51. doi: 10.1016/j.leukres.2009.10.016. Epub 2009 Nov 18. Leuk Res. 2010. PMID: 19926132

10

Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Kovacic N, Grcevic D, Katavic V, Lukic IK, Grubisic V, Mihovilovic K, Cvija H, Croucher PI, Marusic A. Kovacic N, et al. Among authors: croucher pi. Lab Invest. 2010 Mar;90(3):402-13. doi: 10.1038/labinvest.2009.144. Epub 2010 Jan 18. Lab Invest. 2010. PMID: 20084056 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page